Turn Therapeutics Joins U.S. Bancorp | BTIG Fireside Chat on Atopic Dermatitis Program

Bitget2026/10/21 20:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Turn Therapeutics will participate in a U.S. Bancorp | BTIG virtual fireside chat on October 28, 2026, at 10 a.m. ET.
CEO Bradley Burnam and Executive Clinical and Regulatory Lead Stephen M. Hahn will discuss GX-03 development strategy for atopic dermatitis patient access.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turn Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610211601BIZWIRE_USPR_____20261021_BW279897) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Turn Therapeutics Joins U.S. Bancorp | BTIG Fireside Chat on Atopic Dermatitis Program

You may also like

Crypto prices